Superworth

aTYR PHARMA INC EPS ATYR

Diluted earnings per share by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
−$0.62
Latest quarter, Q2 FY26
−$0.11
Fiscal year 2025
−$0.79

aTYR PHARMA INC's earnings per share was −$0.62 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.11.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.79n/a
FY2024−$0.87n/a
FY2023−$0.96n/a
FY2022−$1.60n/a
FY2021−$1.88n/a
FY2020−$1.58n/a
FY2019−$7.35n/a
FY2018−$16.19n/a
FY2017−$26.46n/a
FY2016−$34.16n/a
FY2015−$158.34n/a
FY2014−$416.22n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.11n/a−$0.62
Q1 FY26−$0.11n/a−$0.73
Q4 FY25−$0.14n/a−$0.79
Q3 FY25−$0.26n/a−$0.83
Q2 FY25−$0.22n/a−$0.80
Q1 FY25−$0.17n/a−$0.81
Q4 FY24−$0.18n/a−$0.87
Q3 FY24−$0.23n/a−$0.94
Q2 FY24−$0.23n/a−$0.91
Q1 FY24−$0.23n/a−$0.90
Q4 FY23−$0.25n/a−$0.96
Q3 FY23−$0.20n/a−$0.97

Against its peers

Companies in Healthcare nearest aTYR PHARMA INC's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ATYRaTYR PHARMA INC−$0.62
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on aTYR PHARMA INC

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.